Banking and finance dispute resolution
For the latest news and comment on banking and finance disputes.
For the latest news and comment on banking and finance disputes.
For all the latest news and comment in clinical negligence healthcare law
This collection looks at the latest news and comment on commercial contracting healthcare law. With the health and social care sector under…
For all the latest news and comment in employment and pensions healthcare law
For all the latest legal and regulatory news and comment in health technology
This collection contains DAC B eachcroft's latest report, The Route to Integrated Healthcare , which provides the first practical examples of how…
This collection looks at the latest strategic, commercial, regulatory and negligence legal and advisory news and comment in health and social care. …
For all the latest news and comment on employment and pensions law.
DAC Beachcroft Dublin specialises in insurance, professional indemnity, defendant personal injury, health, commercial litigation and employment work.…
For all the latest new and comment in tax law.
The GC Collective collection offers insight and comment for General Counsels (GCs) and in-house legal teams.
For the latest news and comment on Corporate, M&A and Equity Capital Markets.
Analysis, commentary and checklists on the legal and governance implications of Brexit on businesses operating in, and trading with, the UK
The Accountant's Liability Collection brings you topical news and insight of interest to accountants, actuaries, trustees and other financial…
Events and online training for the health and social care sector.
DAC Beachcroft's LatAm Quarterly Newsletter discusses topical news and issues in Latin America
In response to client suggestions and requests, DAC Beachcroft's insurance sector flagship publication.
For all the latest legal and regulatory news and comment in health and social care integration
For all the latest news and comment in corporate regulatory healthcare law
Find advice, commentary and thought leadership on all aspects of Director's & Officer's Insurance; from contract formation through to complex…
This collection looks at the latest news, comment and development on the law affecting mental health services. The law affecting mental health…
Our market-leading Information Law team regularly publish articles and updates addressing the ever-evolving Information Law landscape.
This collection looks at our Safety, Health and Environment Team and the products and services they can provide. In the climate of increased…
The Insurance Act 2015 comes into force in August 2016 and will represent a significant change to insurance contract law in this country. This…
Legislative changes are bringing major changes to the Insurance landscape. This collection houses DAC Beachcroft's alerts on the pertinent issues.
For all the latest news and comment in clinical regulatory healthcare law
Organisations face ever-increasing expectations from Government, regulators, customers or service users, and other stakeholders, so scrutiny and…
For all the latest legal and regulatory news and comment in healthcare estates and facilities management
This collection addresses the full spectrum of cyber security and data risk management – the zeitgeist of our age.
We have acted for clients in the majority of significant product liability cases that have been decided in the UK over the last 35 years. Our product…
Considering the future landscapes of our cities
The European General Data Protection Regulation (GDPR) came into force on 25 May 2016. A rewrite of European data protection law, the GDPR imposes…
Considering the future of housing
For the latest news and comment on public procurement law.
Welcome to the Construction Risks collection. This space is used to report upon issues of interest to those who seek to allocate, manage and reduce…
Technology, brands and intellectual capital are key assets for any successful business. Our intellectual property (IP) team are experts at helping…
Considering the future of retail
The Insurance Market Conditions and Trends report is DAC Beachcroft's insurance sector flagship publication. Now in its tenth year, the report…
The Solicitors' Risk Collection addresses issues and developments affecting legal practitioners, and the professional indemnity insurers of legal…
Published On: 4 January 2016
This is the third in a series of articles which examine the process by which the PSI supervises pharmacists and pharmacies and their compliance with the Pharmacy Act 2007 (the "2007 Act"). The Supreme Court decision in Corbally v. The Medical Council, Ireland and the Attorney General  IESC 9, which was decided just over a year ago, was viewed as a decision likely to cause professional regulators such as the PSI to tread more carefully in fitness to practise proceedings against professionals. One year on from this landmark judgment we examine if and how the judgment has impacted on the pharmacy sector.
By way of brief reminder, Professor Martin Corbally was a consultant paediatric surgeon at Our Lady's Hospital for Sick Children, Crumlin. In a handwritten note he incorrectly described the procedure to be carried out as an excision of "upper lingual frenulum". However this note did not have any causative effect in relation to the unfortunate incident which followed.
Unfortunately, the IT system in use in Crumlin Hospital at the time had only one code for all three types of frenula dissection and this is what was recorded on the system and in turn what led to the incorrect procedure being carried out on the child (not by Professor Corbally). Ultimately, a corrective procedure was carried out the same day and the child made a full recovery.
Despite the fact that his initial error was not causative of the incorrect procedure, Professor Corbally was found guilty of 'poor professional performance' by the Medical Council and received an 'admonishment'. Professor Corbally instituted judicial review proceedings before the High Court seeking to quash the determination of the Medical Council. The High Court quashed both the decision of the Medical Council imposing the admonishment and the underlying finding of its Fitness to Practise Committee of poor professional performance. The Medical Council appealed the High Court decision to the Supreme Court however the High Court decision was upheld, and if anything reinforced, by the Supreme Court.
There has been much academic discussion regarding the implications of the Supreme Court decision. The Supreme Court handed down three judgments that, in places, appear contradictory and that present an obstacle to properly defining poor professional performance (and as a consequence professional misconduct). It is fair to say that aspects of the law concerning poor professional performance in particular are in a state of flux.
The three judgements are consistent on certain issues and as a consequence a number of things can be said with a degree of certainty:
Even though the Supreme Court was primarily concerned with poor professional performance, the corollary of the decision is that points 2-5 above apply as equally to professional misconduct as they do to poor professional performance. If nothing that is not serious can be poor professional performance, then it necessarily follows (whatever the distinction between poor professional performance and professional misconduct) that nothing that is not serious can be professional misconduct.
Under the 2007 Act, professional misconduct is defined as including any breach of the PSI's Code of Conduct. It would be very troubling indeed if even a minor or inconsequential breach of the Code of Conduct could constitute professional misconduct.
At the time of the Supreme Court decision, the PSI, like many other regulators, indicated that it had been applying High Court judgement in Corbally since it was handed down and would consider any further implications arising from the Supreme Court decision.
The rather basic reasoning and detail in published decisions of committees of inquiry makes it difficult to determine whether the Corbally decision is being applied (as indeed does the disagreement regarding what exactly Corbally decided).
Our impression from our experience in practice has been that committees of inquiry have taken on board the Corbally decision, but in circumstances where we don’t know what principles the PSI says it is applying from Corbally, it means it is not possible to tell whether the PSI is applying those principles.
It is fair to say however that to date there has been no indication that fitness to practice regulators such as the PSI have been more inclined to seek to impose sanctions which required the approval of the High Court (i.e. all sanctions apart from admonishment or censure), thereby providing them with the safety net of having the High Court making the final decision.
The Corbally decision also raised questions as regards the advice a fitness to practice committee such as the Professional Conduct Committee of the PSI may be given by its legal assessor. In Professor Corbally's case, the advice of the legal assessor to the Fitness to Practice Committee was ignored by the committee. Accordingly, Professor Corbally's legal team never had an opportunity during the hearing before the committee to comment on the basis on which the committee were actually going to approach the question of whether poor professional performance had been made out. It appeared to the Supreme Court that this alone might be sufficient to quash the decision.
In our experience, committees of inquiry can still refuse to follow the advice of their legal assessor, but pharmacists are offered an opportunity to comment on the fact a committee does not propose to follow its legal advice.
There are certain issues which the PSI and the other regulators simply cannot address. For example, under the 2007 Act a pharmacist has no right of appeal against a sanction of admonishment or censure, despite such sanctions being potentially very serious indeed when it comes to the reputation of the pharmacist. The PSI does not have the power to remedy this.
The Fine Gael / Labour Government's Autumn 2015 legislative programme had indicated that a Health (Miscellaneous Provisions) Bill would be published during the Autumn / Spring session of the Dáil which would propose to amend the Medical Practitioners Act 2007, the Dental Act 1985, the Health and Social Care Professionals Act 2005, the 2007 Act and the Nurses and Midwives Act 2011 to provide for an appeal against minor sanctions. No such Bill was published.
The last indication from Minister Varadkar prior to the election was that the Department was still working on the Bill. It remains to be seen how high on the list of priorities such a Bill would be for a new Government.
The right of appeal against admonishment is also a factor in the case of Akpepke v. The Medical Council, a case which is currently under appeal to the Supreme Court. Importantly, because the challenge by Professor Corbally to the constitutionality of the Medical Practitioners Act 2007 and its compatibility with the European Convention on Human Rights was not determined pending the judicial review of the Medical Council's decision, the lack of appeal issue remains open.
If there is to be legislation amending the 2007 Act to provide for a right of appeal against minor sanctions, the opportunity should be taken to address some of the other shortcomings of the fitness to practise processes in the 2007 Act, including the following:
While the Corbally decision has been a landmark judgment, many of the matters addressed by it remain somewhat uncertain in their application to fitness to practise proceedings. It is difficult to discern the extent to which the PSI is applying the Corbally decision and in any event there is limited scope for the PSI to address some of the issues which arose in Corbally.
It is hoped that a new Government will recognise the shortcomings of current fitness to practise processes and make changes above and beyond the minimum of change required to ensure the 2007 Act is consistent with Corbally.
Gary Rice, Aidan Healy and Niall Sexton of DAC Beachcroft Solicitors (01 231 9600) are specialists in the commercial and regulatory issues which arise for pharmacies and pharmacists. DAC Beachcroft, a global law firm, is a recognised market leader in healthcare law. This article is for general information purposes only and does not comprise legal advice on any particular matter. You should not rely on any of the material in this article without seeking appropriate legal advice.